FDA NDC Directory · JSON-LD · Markdown

cytarabine

NDC 25021-229 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerSagent Pharmaceuticals
Marketing categoryAbbreviated NDA (generic) · App ANDA211937
Dosage form / routeINJECTION, SOLUTION · INTRATHECAL INTRAVENOUS SUBCUTANEOUS
Active ingredientsCYTARABINE (20 mg/mL)
Marketing started20230601
Package count1

External sources

Source: openFDA. Public-domain (CC0).